Endotypes of allergic diseases and asthma: An important step in building blocks for the future of precision medicine (Q26747302)

Allergology International

Europe PubMed Central

title

Endotypes of allergic diseases and asthma: An important step in building blocks for the future of precision medicine (English)

0 references

0 references

2

Cezmi A Akdis

0 references

Ioana Agache

series ordinal

1

object named as

Ioana Agache

0 references

language of work or name

English

0 references

publication date

July 2016

0 references

published in

0 references

volume

65

0 references

page(s)

243-52

0 references

issue

3

0 references

cites work

Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Remodeling changes of the upper airway with chronic rhinosinusitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Interleukin-9 and interleukin-17C in chronic rhinosinusitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

The metabolomics of asthma control: a promising link between genetics and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma: Effects Across a Broad Range of Eosinophil Counts

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Barrier Epithelial Cells and the Control of Type 2 Immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

IL-17-producing T cells in lung immunity and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Innate lymphoid cells and asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Identification of novel immune phenotypes for allergic and nonallergic childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Blood DNA methylation biomarkers predict clinical reactivity in food-sensitized infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

DNA methylation and childhood asthma in the inner city

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Distinct endotypes of steroid-resistant asthma characterized by IL-17A(high) and IFN-γ(high) immunophenotypes: Potential benefits of calcitriol

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Gene expression profiling of asthma phenotypes demonstrates molecular signatures of atopy and asthma control.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3-like protein 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Toward precision medicine and health: Opportunities and challenges in allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Biomarkers in asthmatic patients: Has their time come to direct treatment?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Precision medicine and precision health: Building blocks to foster a revolutionary health care model

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Omalizumab in asthma: an update on recent developments

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Increased serum IL-17 is an independent risk factor for severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Strategic paths for biomarker qualification

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

1 reference

7 January 2021

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Multidimensional endotypes of asthma: topological data analysis of cross-sectional clinical, pathological, and immunological data.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

IL-17A as an Inducer for Th2 Immune Responses in Murine Atopic Dermatitis Models

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Neutralizing TNFα restores glucocorticoid sensitivity in a mouse model of neutrophilic airway inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated helminth expulsion

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Chitinase-like proteins promote IL-17-mediated neutrophilia in a tradeoff between nematode killing and host damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Identify asthma genes across three phases based on protein-protein interaction network

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Mepolizumab and exacerbations of refractory eosinophilic asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Lebrikizumab treatment in adults with asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Dupilumab in persistent asthma with elevated eosinophil levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Dupilumab treatment in adults with moderate-to-severe atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Mepolizumab treatment in patients with severe eosinophilic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Precision medicine--personalized, problematic, and promising

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Early predictors of asthma and allergy in children: the role of epigenetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

From phenotypes to endotypes to asthma treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Disease phenotyping in chronic obstructive pulmonary disease: the neutrophilic endotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

BCL-2 protects human and mouse Th17 cells from glucocorticoid-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Association of season of birth with DNA methylation and allergic disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Epidermal filaggrin deficiency mediates increased systemic T-helper 17 immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Increased IL-17A secreting CD4+ T cells, serum IL-17 levels and exhaled nitric oxide are correlated with childhood asthma severity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Staphylococcus epidermidis and biofilm-associated neutrophils in chronic rhinosinusitis. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Impaired macrophage phagocytosis in non-eosinophilic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Untangling asthma phenotypes and endotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Predicting intermediate phenotypes in asthma using bronchoalveolar lavage-derived cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

The Imbalance of Th17 cells and CD4(+) CD25(high) Foxp3(+) Treg cells in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Defective IL-10 expression and in vitro steroid-induced IL-17A in paediatric severe therapy-resistant asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Innate immune activation in neutrophilic asthma and bronchiectasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Overview of biomarkers and surrogate endpoints in drug development

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

A Glimpse to Background and Characteristics of Major Molecular Biological Networks

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Th17 Cytokines Disrupt the Airway Mucosal Barrier in Chronic Rhinosinusitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

T-helper type 2-driven inflammation defines major subphenotypes of asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Obese individuals with asthma preferentially have a high IL-5/IL-17A/IL-25 sputum inflammatory pattern.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Noninvasive analysis of the sputum transcriptome discriminates clinical phenotypes of asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Differential gene expression and cytokine production from neutrophils in asthma phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Decision tree-based method for integrating gene expression, demographic, and clinical data to determine disease endotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Anti-inflammatory deficiencies in neutrophilic asthma: reduced galectin-3 and IL-1RA/IL-1β.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Methylomic markers of persistent childhood asthma: a longitudinal study of asthma-discordant monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Multivariate Adaptive Regression Splines

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Mental stress in atopic dermatitis--neuronal plasticity and the cholinergic system are affected in atopic dermatitis and in response to acute experimental mental stress in a randomized controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Lymphotoxin β receptor signaling induces IL-8 production in human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Data-driven asthma endotypes defined from blood biomarker and gene expression data

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Differential serum protein markers and the clinical severity of asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

CD209a expression on dendritic cells is critical for the development of pathogenic Th17 cell responses in murine schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Epigenome-wide association study reveals longitudinally stable DNA methylation differences in CD4+ T cells from children with IgE-mediated food allergy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021

Cellular phenotyping of chronic rhinosinusitis with nasal polyps.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ALIT.2016.04.011

7 January 2021